Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00822692 · ClinicalTrials.gov registry record · NA
Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection
A NA study, sponsored by 59th Medical Wing.
- Completed
- Registry status
- NA
- Development phase
- 139
- Enrollment target
NCT00822692 is a NA study that has completed, run by 59th Medical Wing. The registered enrollment target is 139 participants.
The verdict
NCT00822692, a NA study, has completed, sponsored by 59th Medical Wing.
- COMPLETED
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
Study Summary
Patients will be enrolled in a multi-center study (Wilford Hall Medical Center and Brooke Army Medical Center) to prospectively evaluate outcome after treatment for an uncomplicated skin abscess.
Interventions
- DRUG placebo
- DRUG Trim/ Sulfa DS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00822692
The ClinicalTrials.gov registry entry for NCT00822692 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 59th Medical Wing, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00822692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00822692 about?
NCT00822692 is a clinical study titled "Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection". Patients will be enrolled in a multi-center study (Wilford Hall Medical Center and Brooke Army Medical Center) to prospectively evaluate outcome after treatment for an uncomplicated skin abscess.
What is the current status of trial NCT00822692?
This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2008-07. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00822692?
The interventions under investigation include: placebo (DRUG), Trim/ Sulfa DS (DRUG).
Who is sponsoring clinical trial NCT00822692?
This trial is sponsored by 59th Medical Wing, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.